[
  {
    "ts": null,
    "headline": "Regeneron: Phase III Success In Skin Cancer For Libtayo",
    "summary": "Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating REGN stock with a buy rating.",
    "url": "https://finnhub.io/api/news?id=33c846b2ad9b0efa1662937482989a9d414d14a6b8f04a1376c8e8505345785c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736929800,
      "headline": "Regeneron: Phase III Success In Skin Cancer For Libtayo",
      "id": 132399997,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1437090427/image_1437090427.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating REGN stock with a buy rating.",
      "url": "https://finnhub.io/api/news?id=33c846b2ad9b0efa1662937482989a9d414d14a6b8f04a1376c8e8505345785c"
    }
  },
  {
    "ts": null,
    "headline": "Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy",
    "summary": "Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate PCVX stock as a buy.",
    "url": "https://finnhub.io/api/news?id=8abfda3931b400660ffe40ffc761cb5cac2b4521cf8522657809e87d141614f4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736925320,
      "headline": "Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy",
      "id": 132399353,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate PCVX stock as a buy.",
      "url": "https://finnhub.io/api/news?id=8abfda3931b400660ffe40ffc761cb5cac2b4521cf8522657809e87d141614f4"
    }
  }
]